Landos Biopharma, Inc. (LABP)
NASDAQ: LABP · IEX Real-Time Price · USD
22.15
+0.19 (0.87%)
Apr 23, 2024, 3:37 PM EDT - Market closed
Landos Biopharma Stock Forecast
Stock Price Forecast
The 1 analyst with a 12-month price forecast for Landos Biopharma stock has a target of 20.42, which predicts a decrease of -7.81% from the current stock price of 22.15.
Analyst Consensus: Hold
Analyst Ratings
According to 1 stock analyst, the rating for LABP is "Hold". This means that the analyst believes this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Nov '23 | Dec '23 | Jan '24 | Feb '24 | Mar '24 | Apr '24 |
|---|---|---|---|---|---|---|
| Strong Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 2 | 2 | 2 | 2 | 2 | 1 |
| Sell | 1 | 1 | 1 | 1 | 1 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 3 | 3 | 3 | 3 | 1 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy → Hold Downgrades $50 → $20 | Strong Buy → Hold | Downgrades | $50 → $20 | -7.81% | Apr 1, 2024 |
| Jefferies | Jefferies | Hold → Sell Downgrades $2 → $1 | Hold → Sell | Downgrades | $2 → $1 | -95.49% | Jan 6, 2023 |
| SVB Leerink | SVB Leerink | Hold Maintains $30 → $20 | Hold | Maintains | $30 → $20 | -9.71% | Nov 11, 2022 |
| SVB Leerink | SVB Leerink | Hold Maintains $160 → $30 | Hold | Maintains | $160 → $30 | +35.44% | Aug 12, 2022 |
| Raymond James | Raymond James | Buy → Hold Downgrades n/a | Buy → Hold | Downgrades | n/a | n/a | Aug 12, 2022 |
Financial Forecast
Revenue This Year
n/a
Revenue Next Year
n/a
EPS This Year
-2.23
from -3.50
EPS Next Year
-1.72
from -2.23
Revenue Forecast
| Revenue | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | n/a | n/a | n/a |
| Avg | n/a | n/a | n/a |
| Low | n/a | n/a | n/a |
Revenue Growth
| Revenue Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
EPS Forecast
| EPS | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | -2.13 | -1.37 | -1.25 |
| Avg | -2.23 | -1.72 | -1.21 |
| Low | -2.30 | -2.03 | -1.17 |
EPS Growth
| EPS Growth | 2024 | 2025 | 2026 |
|---|---|---|---|
| High | - | - | - |
| Avg | - | - | - |
| Low | - | - | - |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.